While a good deal of preclinical data on GNRT is available, there are not yet clinical trials in the U.S. Two types of Au nanoparticles have been FDA approved for cancer trials: Au-tumor necrosis factor conjugates (clinicaltrials.gov, NCT00356980) and Au nanoshells for photothermal therapy (AuroLase, currently recruiting, NCT01679470 and NCT00848042 for lung cancer and head and neck cancer, respectively). This evidence concerns the gene TNF and cancer.